Literature DB >> 22977537

Analysis of estrogen receptor isoforms and variants in breast cancer cell lines.

Maie Al-Bader1, Christopher Ford, Bushra Al-Ayadhy, Issam Francis.   

Abstract

In the present study, the expression of estrogen receptor (ER)α and ERβ isoforms in ER-positive (MCF7, T-47D and ZR-75-1) and ER-negative (MDA-MB-231, SK-BR-3, MDA-MB-453 and HCC1954) breast cancer cell lines was investigated. ERα mRNA was expressed in ER-positive and some ER-negative cell lines. ERα Δ3, Δ5 and Δ7 spliced variants were present in MCF7 and T-47D cells; ERα Δ5 and Δ7 spliced variants were detected in ZR-75-1 cells. MDA-MB-231 and HCC1954 cells expressed ERα Δ5 and Δ7 spliced variants. The ERβ1 variant was expressed in all of the cell lines and the ERβ2 variant in all of the ER-positive and some ER-negative cell lines (MDA-MB-231, MDA-MB-453 and SK-BR-3). MCF7, ZR-75-1, MDA-MB-453, HCC1954 and T-47D cells expressed ERβ5. All cell lines expressed an ERα 66-kDa protein band, and some expressed the truncated 42-kDa variant. ERβ1 was detected in all of the cell lines in addition to a 38-44 kDa variant. The results indicate that breast cancer cell lines widely used in research and reported as being ER-negative express ERα and/or ERβ mRNA and protein.

Entities:  

Year:  2011        PMID: 22977537      PMCID: PMC3440683          DOI: 10.3892/etm.2011.226

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  74 in total

1.  The human estrogen receptor-alpha isoform hERalpha46 antagonizes the proliferative influence of hERalpha66 in MCF7 breast cancer cells.

Authors:  Graziella Penot; Christine Le Péron; Yohann Mérot; Eva Grimaud-Fanouillère; François Ferrière; Noureddine Boujrad; Olivier Kah; Christian Saligaut; Bernadette Ducouret; Raphaël Métivier; Gilles Flouriot
Journal:  Endocrinology       Date:  2005-09-08       Impact factor: 4.736

2.  ER beta: identification and characterization of a novel human estrogen receptor.

Authors:  S Mosselman; J Polman; R Dijkema
Journal:  FEBS Lett       Date:  1996-08-19       Impact factor: 4.124

3.  Estrogen receptor beta splice variant mRNAs are differentially altered during breast carcinogenesis.

Authors:  Indra Poola; Jessy Abraham; Aiyi Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2002-10       Impact factor: 4.292

4.  Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue.

Authors:  E Leygue; H Dotzlaw; P H Watson; L C Murphy
Journal:  Cancer Res       Date:  1999-03-15       Impact factor: 12.701

5.  Estrogen receptor beta acts as a dominant regulator of estrogen signaling.

Authors:  K Pettersson; F Delaunay; J A Gustafsson
Journal:  Oncogene       Date:  2000-10-12       Impact factor: 9.867

6.  Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines.

Authors:  Dan Tong; Eva Schuster; Michael Seifert; Klaus Czerwenka; Sepp Leodolte; Robert Zeillinger
Journal:  Breast Cancer Res Treat       Date:  2002-02       Impact factor: 4.872

7.  Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta.

Authors:  G B Tremblay; A Tremblay; N G Copeland; D J Gilbert; N A Jenkins; F Labrie; V Giguère
Journal:  Mol Endocrinol       Date:  1997-03

Review 8.  Estrogen receptor mutations in human disease.

Authors:  Matthew H Herynk; Suzanne A W Fuqua
Journal:  Endocr Rev       Date:  2004-12       Impact factor: 19.871

9.  Estrogen receptor beta expression in invasive breast cancer.

Authors:  S Mann; R Laucirica; N Carlson; P S Younes; N Ali; A Younes; Y Li; M Younes
Journal:  Hum Pathol       Date:  2001-01       Impact factor: 3.466

10.  Variant human breast tumor estrogen receptor with constitutive transcriptional activity.

Authors:  S A Fuqua; S D Fitzgerald; G C Chamness; A K Tandon; D P McDonnell; Z Nawaz; B W O'Malley; W L McGuire
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

View more
  19 in total

1.  Moving Toward Integrating Gene Expression Profiling Into High-Throughput Testing: A Gene Expression Biomarker Accurately Predicts Estrogen Receptor α Modulation in a Microarray Compendium.

Authors:  Natalia Ryan; Brian Chorley; Raymond R Tice; Richard Judson; J Christopher Corton
Journal:  Toxicol Sci       Date:  2016-02-10       Impact factor: 4.849

Review 2.  Most recent strategies targeting estrogen receptor alpha for the treatment of breast cancer.

Authors:  Nitish Kumar; Harmandeep Kaur Gulati; Aakriti Sharma; Shilpa Heer; Anupmjot Kaur Jassal; Lovenish Arora; Simranpreet Kaur; Atamjit Singh; Kavita Bhagat; Arshmeet Kaur; Harbinder Singh; Jatinder Vir Singh; Preet Mohinder Singh Bedi
Journal:  Mol Divers       Date:  2020-09-04       Impact factor: 2.943

Review 3.  Unconventional Estrogen Signaling in Health and Disease.

Authors:  Christina L Faltas; Kira A LeBron; Marina K Holz
Journal:  Endocrinology       Date:  2020-04-01       Impact factor: 4.736

4.  PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.

Authors:  Mitchell B Rosen; Kaberi P Das; John Rooney; Barbara Abbott; Christopher Lau; J Christopher Corton
Journal:  Toxicology       Date:  2017-05-27       Impact factor: 4.221

5.  Pressure regulated basis for gene transcription by delta-cell micro-compliance modeled in silico: Biphenyl, bisphenol and small molecule ligand models of cell contraction-expansion.

Authors:  Hemant Sarin
Journal:  PLoS One       Date:  2020-10-06       Impact factor: 3.240

6.  AroER tri-screen is a biologically relevant assay for endocrine disrupting chemicals modulating the activity of aromatase and/or the estrogen receptor.

Authors:  Shiuan Chen; Dujin Zhou; Li-Yu Hsin; Noriko Kanaya; Cynthie Wong; Richard Yip; Srilatha Sakamuru; Menghang Xia; Yate-Ching Yuan; Kristine Witt; Christina Teng
Journal:  Toxicol Sci       Date:  2014-02-04       Impact factor: 4.849

7.  A Series of Indole-Thiazole Derivatives Act as GPER Agonists and Inhibit Breast Cancer Cell Growth.

Authors:  Austin O'Dea; Chelsea Sondergard; Patrick Sweeney; Christopher Kent Arnatt
Journal:  ACS Med Chem Lett       Date:  2018-09-04       Impact factor: 4.345

8.  Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity.

Authors:  Adam W Nelson; Arnoud J Groen; Jodi L Miller; Anne Y Warren; Kelly A Holmes; Gerard A Tarulli; Wayne D Tilley; Benita S Katzenellenbogen; John R Hawse; Vincent J Gnanapragasam; Jason S Carroll
Journal:  Mol Cell Endocrinol       Date:  2016-11-23       Impact factor: 4.102

9.  The regulation of hydroxysteroid 17β-dehydrogenase type 1 and 2 gene expression in breast cancer cell lines by estradiol, dihydrotestosterone, microRNAs, and genes related to breast cancer.

Authors:  Erik Hilborn; Olle Stål; Andrey Alexeyenko; Agneta Jansson
Journal:  Oncotarget       Date:  2017-07-10

10.  The Impacts of Genistein and Daidzein on Estrogen Conjugations in Human Breast Cancer Cells: A Targeted Metabolomics Approach.

Authors:  Stefan Poschner; Alexandra Maier-Salamon; Martin Zehl; Judith Wackerlig; Daniel Dobusch; Bettina Pachmann; Konstantin L Sterlini; Walter Jäger
Journal:  Front Pharmacol       Date:  2017-10-05       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.